Core Technologies

HAEAMBIO Co., Ltd. leverages its network with leading hospitals and research institutions both domestically and internationally to identify new targets for heart disease treatment. Based on this foundation, we have secured core technologies such as patient-derived valve cell isolation, gene profiling, and the discovery and validation of calcification-related genes.

Core Technology IEstablishment of a Valve Tissue Bank for Aortic Valve Disease Research

keyboard_arrow_down

Core Technology II Technology for Isolation of Patient-Derived Valve Interstitial Cells (VIC)

keyboard_arrow_down

Core Technology III Gene Profiling of Patient-Derived Valve Interstitial Cells (VIC)

keyboard_arrow_down

Core Technology IV Acquisition of Single-Cell Sequencing Data from Patient-Derived Heart Valves

keyboard_arrow_down

Core Technology V Identification and Validation of Target Genes Related to Calcification

keyboard_arrow_down

Core Technology VIDevelopment of an Animal Model for Valve Calcification

keyboard_arrow_down

Core Technology VIIEvaluation of Therapeutic Efficacy Using the Valve Calcification Animal Model

keyboard_arrow_down

Core Technology VIII Development of a Myocardial Infarction Mouse Model and Expertise in Exploring Therapeutic Agents (Cell Therapy, Related Genes)

keyboard_arrow_down